Saša Perović has been Market Access Manager for South East Europe at Hemofarm A.D. since 2015. Prior to joining Hemofarm, he served as Market Access Manager for Serbia and Montenegro at Bayer for nearly four years. Earlier in his career, he spent almost a decade as Executive Director of the National Health Insurance Fund of Serbia.

Founded in 1960, Hemofarm A.D. is currently the leading generic pharmaceutical company in Serbia and in the region. Manufacturing high quality, effective, safe and affordable pharmaceutical products is the core activity of the company. Since 2006, Hemofarm has been a part of the German STADA Group, one of the largest generic pharmaceutical companies in the world. Hemofarm is the leader on the pharmaceutical market of Serbia. Taking up over 70% of the total exports of pharmaceutical products, the Vršac-based company is at the same time the largest Serbian exporter of drugs. Hemofarm manufactures about 6.6 billion tablets and capsules annually. It operates on four continents and it has a team of over 3,600 employees. In addition to being present on 34 markets around the World, Hemofarm is among the largest pharmaceutical manufacturers in this region.